Page last updated: 2024-08-22

helenalin and cd 437

helenalin has been researched along with cd 437 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, LW; Jin, F; Khuri, FR; Liu, X; Lotan, R; Sun, SY; Yue, P; Zhou, Z1

Other Studies

1 other study(ies) available for helenalin and cd 437

ArticleYear
Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
    Cancer research, 2005, Jul-15, Volume: 65, Issue:14

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 8; Caspases; Cell Line, Tumor; Humans; I-kappa B Proteins; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Retinoids; Sesquiterpenes; Sesquiterpenes, Guaiane; Up-Regulation

2005